Series A Completed

Solstice Oncology Series A

US$225m raised

Announced 9 Sep 2026

Investors

Investors

Investors as the sources name them; a linked name has a FundComb profile.

Company
Solstice Oncology
Stage
Series A
Amount raised
US$225m
Company based in
United States
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

Similar rounds

All Series A rounds →

Sources

Suggest a correction

A missing investor, a different lead, amount or date. A link to a public source helps.